Drugs

  • Great expectations? How carers view Aricept

    When new drug treatments for Alzheimer’s disease were launched last year, professionals feared that all the publicity could create false hopes among carers and relatives. However, this study by Frances Vaughan, Robert Jones and Louise Cunliffe showed that most carers’ expectations were consistent with the clinical information they had been given. Author/s: Frances Vaughan, Robert…...

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Haloperidol, hips and toenails

    Mrs T’s “calming” medication was having the opposite effect and she posed a huge challenge for staff. Without the drug she began to emerge as a person, and staff could begin a long but effective process of discovery and individualised care. By Tracy Packer and Michelle Jefferies. Author/s: Tracy Packer, Michelle Jefferies For the full…...

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Antipsychotic drugs: their use and misuse

    Do antipsychotic drugs have a role in good dementia care practice? Following warnings of overuse in some care settings, Marc Lestor and James Warner give guidance on when these drugs may be effective and useful, and when they should not be used. Author/s: Marc Lestor, James Warner For the full article please see the PDF…...

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Launched with a quiet fanfare

    Excitement was kept under firm control at the launch of the first UK drug for Alzheimer’s disease. For a lucky few it is certainly beneficial, but as potential demand is so huge, financial and ethical issues must be faced. Robert Short describes the effects and efficacy of donepezil (Aricept). Author/s: Robert Short For the full…...

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • A small step forward

    Aricept may be good news in the long term, but for now it will increase demands on hard-pressed services, writes Harry Cayton. Author/s: Harry Cayton For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Prescribing a hazy future

    The use of drugs to improve cognitive ability raises important ethical questions. Anthea Tinker and colleagues outline the issues we should all urgently consider. Author/s: Anthea Tinker For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • How and why to keep taking the tablets

    Many people with dementia also have physical conditions needing regular medication, but their ability to take drugs regularly, and as instructed, is impaired. Alison Ewing explains how a pharmacist can help, and describes the variety of compliance aids available. Author/s: Alison Ewing For the full article please see the PDF download linked to the right…....

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Many a slip ‘twixt dose and lip

    Monitored dosage is a useful time-saving system of drug administration, but it does bring its own limitations and dangers. Sally Kennedy shares some words of warning after using the system for five years. Author/s: Sally Kennedy For the full article please see the PDF download linked to the right. The full JDC archive is available…...

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Understanding dementia 9: Drug treatments for psychiatric and behaviour disturbances

    Dr Robert Tobiansky reviews research and clinical experience on the use of drugs to help carers and staff cope with behaviour disturbances in dementia. Author/s: Robert Tobiansky For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here

  • Understanding dementia 10

    Drug treatments for depression and anxiety, and use of hypnotic drugs. Author/s: Robert Tobiansky For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

    Restricted Content

    Most Journal articles are only accessible to Journal Subscribers. Some other content is only accessible to Society Members.

    Enable access

    Already a Society Member and/or a Journal Subscriber? Log in here